Gunjal Garg

Summary

Publications

  1. ncbi request reprint Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis
    Gunjal Garg
    Division of Gynecologic Oncology, Washington University School of Medicine, Siteman Cancer Center, St Louis, MO, USA Electronic address
    Gynecol Oncol 133:242-9. 2014
  2. ncbi request reprint Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?
    Gunjal Garg
    Division of Gynecologic Oncology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO 63110, USA
    Gynecol Oncol 129:538-43. 2013
  3. doi request reprint The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer
    Gunjal Garg
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO 63110, USA
    Int J Gynecol Cancer 23:90-7. 2013
  4. doi request reprint Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer
    Gunjal Garg
    Division of Gynecologic Oncology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO, USA
    Gynecol Oncol 128:77-82. 2013
  5. doi request reprint Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants
    Gunjal Garg
    Department of Obstetrics and Gynecology, University of Rochester, Rochester, NY, USA
    Int J Gynecol Cancer 21:1606-12. 2011
  6. doi request reprint Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer
    Gunjal Garg
    Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA
    Gynecol Oncol 123:208-13. 2011
  7. ncbi request reprint Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
    G Garg
    Department of Obstetrics and Gynecology Detroit Medical Center, Detroit, MI, USA
    Gynecol Oncol 118:8-13. 2010
  8. doi request reprint Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA
    Int J Gynecol Cancer 21:711-6. 2011
  9. doi request reprint Intra-operative detection of nodal metastasis in early stage cervical cancer: a survey of the practice patterns of SGO members
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA
    Gynecol Oncol 121:143-7. 2011
  10. doi request reprint Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA
    Int J Gynecol Cancer 20:1201-6. 2010

Detail Information

Publications18

  1. ncbi request reprint Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis
    Gunjal Garg
    Division of Gynecologic Oncology, Washington University School of Medicine, Siteman Cancer Center, St Louis, MO, USA Electronic address
    Gynecol Oncol 133:242-9. 2014
    ..To examine the patterns of care, predictors, and impact of chemotherapy on survival in elderly women diagnosed with early-stage uterine carcinosarcoma...
  2. ncbi request reprint Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?
    Gunjal Garg
    Division of Gynecologic Oncology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO 63110, USA
    Gynecol Oncol 129:538-43. 2013
    ..To identify those patients with gynecologic cancers and intestinal perforation in whom conservative management may be appropriate...
  3. doi request reprint The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer
    Gunjal Garg
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO 63110, USA
    Int J Gynecol Cancer 23:90-7. 2013
    ..To determine the correlation between positive peritoneal cytology (PPC) and lymph node metastasis in patients with endometrial cancer grossly confined to the uterus...
  4. doi request reprint Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer
    Gunjal Garg
    Division of Gynecologic Oncology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO, USA
    Gynecol Oncol 128:77-82. 2013
    ....
  5. doi request reprint Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants
    Gunjal Garg
    Department of Obstetrics and Gynecology, University of Rochester, Rochester, NY, USA
    Int J Gynecol Cancer 21:1606-12. 2011
    ....
  6. doi request reprint Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer
    Gunjal Garg
    Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, USA
    Gynecol Oncol 123:208-13. 2011
    ..To determine the prognostic significance of location of lymph node metastasis and extranodal disease for women with stage IIIC endometrial cancer...
  7. ncbi request reprint Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
    G Garg
    Department of Obstetrics and Gynecology Detroit Medical Center, Detroit, MI, USA
    Gynecol Oncol 118:8-13. 2010
    ..To determine the correlation of the new FIGO staging system with survival in stage I patients with low-grade and high-grade endometrial stromal sarcomas...
  8. doi request reprint Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA
    Int J Gynecol Cancer 21:711-6. 2011
    ....
  9. doi request reprint Intra-operative detection of nodal metastasis in early stage cervical cancer: a survey of the practice patterns of SGO members
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA
    Gynecol Oncol 121:143-7. 2011
    ..To determine the practice patterns of members of Society of Gynecologic Oncologists (SGO) in different clinical situations involving the intra-operative detection of nodal metastasis in early stage cervical cancer...
  10. doi request reprint Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA
    Int J Gynecol Cancer 20:1201-6. 2010
    ..In this large population-based study, we validate the use of tumor size for purposes of risk stratification among stage I leiomyosarcoma patients...
  11. doi request reprint Should radical hysterectomy be aborted on intraoperative detection of nodal tumor metastasis in early stage cervical cancer?
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA
    J Low Genit Tract Dis 14:374-81. 2010
    ..Here, we present a review of the literature regarding clinical management of patients with ESCC with intraoperative diagnosis of nodal metastasis...
  12. doi request reprint Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI 48201, USA
    Int J Gynecol Cancer 20:888-94. 2010
    ..The objective of this study was to identify site-specific differences by comparing carcinosarcomas originating in the uterus and the ovaries...
  13. doi request reprint The impact of a multidisciplinary conference in the management of cervical cytological and histological abnormalities: a university hospital experience
    Gunjal Garg
    Department of Obstetrics and Gynecology, Detroit Medical Center, Wayne State University, Detroit, MI, USA
    J Low Genit Tract Dis 14:215-20. 2010
    ..This study evaluates the impact of a cytology-colposcopy correlation conference (CCCC) on the management of preinvasive cervical lesions in a university hospital...
  14. ncbi request reprint Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134
    Yassar M Hashim
    Department of Surgery, Washington University School of Medicine, St Louis, MO, United States
    Mol Oncol 8:956-67. 2014
    ..Our data support further study of this novel therapeutic and this drug delivery strategy because it may eventually benefit patients with pancreatic cancer. ..
  15. ncbi request reprint Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer
    Gunjal Garg
    Department of Surgery, Washington University School of Medicine, 660 S, Euclid Avenue, Campus Box 8109, St, Louis, MO 63110, USA
    Mol Cancer 13:50. 2014
    ..Additionally, because sigma-2 receptors are preferentially expressed in tumor cells, their ligands provide an effective mechanism for selective anti-cancer therapy...
  16. doi request reprint Prognostic analysis of ovarian cancer associated with endometriosis
    Sanjeev Kumar
    Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA
    Am J Obstet Gynecol 204:63.e1-7. 2011
    ..The objective of the study was to evaluate the prognosis of ovarian cancer arising in endometriosis...
  17. ncbi request reprint Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3
    Gunjal Garg
    Department of Surgery, Washington University School of Medicine, St, Louis, MO 63110, USA
    BMC Cancer 14:35. 2014
    ..In order to deliver TR3 selectively to MUC16-expressing cancers, we investigated the possibility of targeted TR3 delivery employing the high affinity mesothelin/MUC16 ligand/receptor interaction...